CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $404,424 | -92.5% | 8,910 | -90.8% | 0.00% | -100.0% |
| Q2 2023 | $5,411,783 | +2034.2% | 96,398 | +1445.3% | 0.01% | – |
| Q4 2022 | $253,574 | -93.7% | 6,238 | -89.9% | 0.00% | -100.0% |
| Q3 2022 | $4,022,000 | +667.6% | 61,545 | +614.4% | 0.01% | +400.0% |
| Q2 2022 | $524,000 | -0.4% | 8,615 | +2.8% | 0.00% | 0.0% |
| Q1 2022 | $526,000 | +1.7% | 8,383 | +22.8% | 0.00% | 0.0% |
| Q4 2021 | $517,000 | -89.1% | 6,827 | -83.9% | 0.00% | -80.0% |
| Q3 2021 | $4,734,000 | +25.4% | 42,297 | +36.5% | 0.01% | 0.0% |
| Q1 2021 | $3,775,000 | -62.1% | 30,979 | -52.3% | 0.01% | -61.5% |
| Q4 2020 | $9,952,000 | +79.4% | 65,002 | -2.0% | 0.01% | +44.4% |
| Q3 2020 | $5,546,000 | +8.7% | 66,311 | -4.5% | 0.01% | 0.0% |
| Q2 2020 | $5,101,000 | +32.0% | 69,409 | -23.8% | 0.01% | 0.0% |
| Q1 2020 | $3,865,000 | +291.6% | 91,133 | +278.4% | 0.01% | +350.0% |
| Q3 2019 | $987,000 | +11.0% | 24,085 | -3.2% | 0.00% | 0.0% |
| Q1 2019 | $889,000 | -8.2% | 24,892 | -26.5% | 0.00% | 0.0% |
| Q4 2018 | $968,000 | -76.6% | 33,869 | -63.7% | 0.00% | -75.0% |
| Q3 2018 | $4,140,000 | -17.2% | 93,347 | +9.8% | 0.01% | -20.0% |
| Q2 2018 | $4,998,000 | – | 85,052 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |